Certified by Founder Lodge
Aer Therapeutics, Inc.
United States - San Francisco, CA
START UP
1 Disclosed Funding Rounds $36,000,000
0 Participating Investments
-
Founded date
2014
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung disease with excess mucus and mucus plugs. We are focused on treating respirat
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 17 ,2023 | Series A | $36,000,000 |
Hatteras Venture Partners
OrbiMed
Canaan
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
